Comparative assessment of skeletal uptake on ⁶⁸Ga-PSMA PET/CT versus ¹⁸F-Fluoride PET/CT in prostate cancer (#84)

8:30 AM

Aviral Singh

Conference Breakfast: Moderated Poster Walk - Prostate tumours

Molecular imaging with ⁶⁴Cu-PSMA PET/CT in Theranostics of prostate cancer (#34)

4:24 PM

Aviral Singh

Improving Patient Outcomes with PSMA Theranostics

¹⁷⁷Lu-PSMA radioligand therapy of prostate cancer in patients with single functioning kidney (#85)

8:30 AM

Aviral Singh

Conference Breakfast: Moderated Poster Walk - Prostate tumours

Efficacy of peptide receptor radionuclide therapy in neuroendocrine neoplasms: the Bad Berka experience in 1048 patients over more than a decade (#64)

8:30 AM

Harshad R Kulkarni

Conference Breakfast: Moderated Poster Walk - Neuroendocrine tumours

Prostate specific membrane antigen targeted radioligand therapy of metastatic castration-resistant prostate cancer using Lu-177 PSMA-617: safety, efficacy and dosimetry in comparison with Lu-177 PSMA I&T (#33)

4:06 PM

Harshad R Kulkarni

Improving Patient Outcomes with PSMA Theranostics

Evaluation of Somatostatin, CXCR4 Chemokine and Endothelin A Receptor Expression in a Large Series of Paragangliomas (#16)

4:15 PM

Aviral Singh

Optimising Peptide Receptor Radionuclide Therapy (PRRT) - (submitted abstracts)